News

FDA approves shot that protects dogs from fleas and ticks for 8-12 months
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
FOX 5 Atlanta3h
Georgia lawmakers unite to urge FDA reversal on drug denial for child with rare disease
Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.
Weaver Nut Company chocolate recall under FDA's highest risk level
The FDA recalled some chocolate products by the Weaver Nut Company chocolate, warning about possible serious to ...
US FDA declines to approve Ultragenyx's gene therapy for rare genetic disorder
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat a rare inherited disorder, citing manufacturing concerns, the company said ...
Senate panel clears FDA appropriations
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Senate panel clears ...
Lawmakers advance $27B funding bill tackling FDA funding, hemp, farm loans
Lawmakers are making slow headway on assembling a fiscal year 2026 package of 12 annual funding bills that provide money for ...
The Daily Signal6hOpinion
RFK’s New Vaccine Team: A Non-Hysterical Assessment
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
US FDA declines to approve Ultragenyx's gene therapy for rare inherited disorder
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat ...
What is Bravecto Quantum? FDA approves 12-month flea and tick treatment
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ticks for up to a year.
Opinion
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
Managed Healthcare Executive8h
Capricor’s DMD Cell Therapy Faces FDA Setback
The company said it was optimistic that the issues identified by the Food and Drug Administration could be resolved with new data.